The presence of AREG is closely linked to the oncogenic process; increasingly higher levels of AREG expression correlate with worse prognosis in several cancers, such as ovarian, glioma, head and neck, breast, and lung cancers 31, 38, 39. Here, AREG is linked to cancer.